O. Deas

发表

NOTCH1 nuclear interactome reveals key regulators of its transcriptional activity and oncogenic function.

B. Sobhian, Y. Lévy, Clarisse Benne, 2012, Molecular cell.

An NF90/NF110-Mediated Feedback Amplification Loop Regulates DICER Expression and Controls Ovarian Carcinoma Progression

W. Ritchie, P. Giraud, X. Contreras, 2018, Cell Research.

Genetic characterization of a unique neuroendocrine transdifferentiation prostate circulating tumor cell-derived eXplant model

S. Cairo, N. Manaresi, N. Stoecklein, 2020, Nature Communications.

The sialyl-glycolipid stage-specific embryonic antigen 4 marks a subpopulation of chemotherapy-resistant breast cancer cells with mesenchymal features

A. Schneeweiss, A. Trumpp, S. Cairo, 2015, Breast Cancer Research.

Caspase-independent cell death induced by anti-CD2 or staurosporine in activated human peripheral T lymphocytes.

G. Cohen, M. MacFarlane, F. Harper, 1998, Journal of immunology.

A RAD51 assay feasible in routine tumor samples calls PARP inhibitor response beyond BRCA mutation

C. Caldas, J. Baselga, S. Cairo, 2018, EMBO molecular medicine.

Feasibility and first reports of the MATCH-R repeated biopsy trial at Gustave Roussy

E. Solary, D. Planchard, A. Eggermont, 2020, npj Precision Oncology.

N6-methyladenosine modification of circNSUN2 facilitates cytoplasmic export and stabilizes HMGA2 to promote colorectal liver metastasis

Jie-Wei Chen, J. Yun, Z. Pan, 2019, Nature Communications.

Potentiation of tumour apoptosis by human growth hormone via glutathione production and decreased NF-κB activity

G. Vassal, J. Bénard, A. Dürrbach, 2003, British Journal of Cancer.

Preclinical In Vivo Validation of the RAD51 Test for Identification of Homologous Recombination-Deficient Tumors and Patient Stratification.

S. Nik-Zainal, C. Caldas, S. Cairo, 2022, Cancer research.

Association of FGFR1 with ERα Maintains Ligand-Independent ER Transcription and Mediates Resistance to Estrogen Deprivation in ER+ Breast Cancer

S. Cairo, K. Hutchinson, A. Guerrero-Zotano, 2017, Clinical Cancer Research.

Targeting genome integrity dysfunctions impedes metastatic potency in non–small cell lung cancer circulating tumor cell–derived explants

S. Cairo, D. Planchard, J. Scoazec, 2022, JCI insight.

The sialyl-glycolipid stage-specific embryonic antigen 4 marks a subpopulation of chemotherapy-resistant breast cancer cells with mesenchymal features

A. Schneeweiss, A. Trumpp, S. Cairo, 2015, Breast Cancer Research.

Thiol-mediated inhibition of FAS and CD2 apoptotic signaling in activated human peripheral T cells.

D. Métivier, B. Charpentier, F. Hirsch, 1997, International immunology.

MiR-205 as predictive biomarker and adjuvant therapeutic tool in combination with trastuzumab

M. Iorio, S. Cairo, E. Tagliabue, 2018, Oncotarget.

Patient‐derived mouse xenografts from pediatric liver cancer predict tumor recurrence and advise clinical management

S. Cairo, E. Fadel, M. Ghigna, 2016, Hepatology.

Activation of IFN/STAT1 signalling predicts response to chemotherapy in oestrogen receptor-negative breast cancer

S. Cairo, S. Vacher, S. Roman-Roman, 2015, British Journal of Cancer.

Human Peripheral T Lymphocytes Anti-CD 2 or Staurosporine in Activated Caspase-Independent Cell Death Induced by

G. Cohen, M. MacFarlane, F. Harper, 1998 .

Diverse Resistance Mechanisms to the Third-Generation ALK Inhibitor Lorlatinib in ALK-Rearranged Lung Cancer

J. Thiery, E. Solary, D. Planchard, 2019, Clinical Cancer Research.

Targeted Vpr-derived peptides reach mitochondria to induce apoptosis of αVβ3-expressing endothelial cells

P. Rustin, C. Péchoux, D. Chauvier, 2007, Cell Death and Differentiation.

The MET Inhibitor AZD6094 (Savolitinib, HMPL-504) Induces Regression in Papillary Renal Cell Carcinoma Patient–Derived Xenograft Models

Rhys D O Jones, S. Cairo, S. Fawell, 2015, Clinical Cancer Research.

In vivo-targeted gene delivery using antibody-based nonviral vector.

E. Oosterwijk, A. Dürrbach, B. Charpentier, 2002, Human gene therapy.

Title: Association of FGFR1 with ER  maintains ligand-independent ER transcription and 1 mediates resistance to estrogen deprivation in ER+ breast cancer 2

S. Cairo, K. Hutchinson, J. Balko, 2017 .

Peripheral blood T cells generated after allogeneic bone marrow transplantation: lower levels of bcl-2 protein and enhanced sensitivity to spontaneous and CD95-mediated apoptosis in vitro. Abrogation of the apoptotic phenotype coincides with the recovery of normal naive/primed T-cell profiles.

B. Charpentier, A. Durrbach, J. Vernant, 1999, Blood.

Growth hormone prevents human monocytic cells from Fas‐mediated apoptosis by up‐regulating Bcl‐2 expression

J. Estaquier, B. Charpentier, F. Hirsch, 1999, European journal of immunology.

Inhibitory effect of growth hormone on TNF-alpha secretion and nuclear factor-kappaB translocation in lipopolysaccharide-stimulated human monocytes.

S. Wright, B. Charpentier, F. Hirsch, 1997, Journal of immunology.

Intracellular STING inactivation sensitizes breast cancer cells to genotoxic agents

S. Cairo, M. Poupon, V. Goffin, 2016, Oncotarget.

A flavivirus protein M-derived peptide directly permeabilizes mitochondrial membranes, triggers cell death and reduces human tumor growth in nude mice

S. Muller, D. Chauvier, R. Casimir, 2009, Apoptosis.

Relationship between proliferation and susceptibility to CD95- and CD2-mediated apoptosis in stimulated primary T lymphocytes: T cells manifesting proliferative unresponsiveness are preferentially susceptible to CD95-mediated apoptosis.

A. Bernard, B. Charpentier, B. Mollereau, 1997, Journal of immunology.

Targeting additional costimulatory pathways: a subtle role for CD2.

B. Charpentier, A. Durrbach, F. Hirsch, 2001, Transplantation proceedings.

Potent apoptotic signaling and subsequent unresponsiveness induced by a single CD2 mAb (BTI-322) in activated human peripheral T cells.

A. Bernard, B. Charpentier, F. Hirsch, 1998, Journal of immunology.

(BTI-322) in Activated Human Peripheral T Cells Unresponsiveness Induced by a Single CD2 mAb Potent Apoptotic Signaling and Subsequent

A. Bernard, Bernard, F. Hirsch, 1998 .

Antibodies, a Potent Tool to Target Genes into Designated Cells and Tissues

A. Durrbach, F. Hirsch, O. Déas, 2004 .

Human growth hormone gene transfer into tumor cells may improve cancer chemotherapy

G. Vassal, J. Merlin, J. Bénard, 2002, Cancer Gene Therapy.

Synergic activity of FGFR2 and MEK inhibitors in the treatment of FGFR2-amplified cancers of unknown primary

M. Ferracin, G. Calin, E. Porcellini, 2023, medRxiv.

An NF90/NF110-Mediated Feedback Amplification Loop Regulates DICER Expression and Controls Ovarian Carcinoma Progression

P. Giraud, X. Contreras, D. Xie, 2018, Cell Research.

Genetic characterization of a unique neuroendocrine transdifferentiation prostate circulating tumor cell-derived eXplant model

S. Cairo, N. Manaresi, N. Stoecklein, 2020, Nature Communications.

Development of Novel Models of Aggressive Variants of Castration-resistant Prostate Cancer.

Y. Loriot, R. Flippot, C. Massard, 2023, European urology oncology.